Supplementary Table S2 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma

<p>Supplementary Table S2. PDX models minimal information standard (PDX-MI).</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Arun Kanakkanthara (14937731) (author)
Eará dahkkit:	Xiaonan Hou (736827) (author), Thomas L. Ekstrom (14937737) (author), Valentina Zanfagnin (15203306) (author), Amelia M. Huehls (14904464) (author), Rebecca L. Kelly (15203309) (author), Husheng Ding (14911926) (author), Melissa C. Larson (14969062) (author), George Vasmatzis (69257) (author), Ann L. Oberg (14937746) (author), Scott H. Kaufmann (14937749) (author), Aaron S. Mansfield (15033804) (author), S. John Weroha (7907816) (author), Larry M. Karnitz (13208232) (author)
Almmustuhtton:	2025
Fáttát:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Chemotherapy Combination chemotherapy DNA Damage and Repair DNA repair Drug Mechanisms Gynecological Cancers Ovarian cancer Preclinical Models
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid